Treating cancer with Thunder of God vine: Celastrol, an antioxidant & anti-inflammatory drug from herb Thunder of God vine, suppresses the expression of NOS2 via up regulation of its target gene, 13/March/2014, 11.45
Noble Laureate in Medicine (1998) Prof. Dr Ferid M (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers. In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Treating cancer with Thunder of God vine: Celastrol, an antioxidant & anti-inflammatory drug […]
Treating cancer with Thunder of God vine: Celastrol, an antioxidant & anti-inflammatory drug from herb Thunder of God vine, suppresses the expression of NOS2 via up regulation of its target gene, 13/March/2014, 11.45
Noble Laureate in Medicine (1998) Prof. Dr Ferid M (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers. In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Treating cancer with Thunder of God vine: Celastrol, an antioxidant & anti-inflammatory drug […]
Insights into Cell-density-dependent miRNA Biogenesis: Menin1 suppresses wide spread miRNA processing via up regulation of its target gene, 13/March/2014, 8.41 am
Prof. Dr Gregory and his co-workers from Boston Children’s Hospital, MA, USA; Department of Biological Chemistry and Molecular Pharmacology and Department of Pediatrics, Harvard Medical School, Boston, MA, USA; and Harvard Stem Cell Institute, Boston, MA, USA had reported in the prestigious journal Cell (Feb 27, 2014) that “Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer” On the foundation of this interesting finding, Dr L Boominathan PhD, […]
Molecular Cancer stem cell therapy: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, suppresses the expression of tumor suppressor p53 negative regulator MDM2 via up regulation of its target gene, 12/March/2014, 22.03
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecular Cancer stem cell therapy: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, suppresses the expression of tumor suppressor p53 negative regulator MDM2 via up regulation of its target gene, 12/March/2014, 22.03, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org * Research cooperation
Insights into the control of mammary cell proliferation: LIFR suppresses the expression of ITGBP2 via up regulation of its target gene, 13/March/2014, 9.21 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into the control of mammary cell proliferation: LIFR suppresses the expression of ITGBP2 via up regulation of its target gene, 13/March/2014, 9.21 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Molecular Cancer stem cell therapy: miRNA-137 increases the expression of tumor suppressor p16 (INK4α) via down regulation of its target gene, 12/March/2014, 21.50
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Molecular Cancer stem cell therapy: miRNA-137 increases the expression of tumor suppressor p16(INK4α) via down regulation of its target gene, 12/March/2014, 21.50, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
